R&D Turning the NHS into a world-leading R&D platform Lord James O'Shaughnessy sets out the basis of his forthcoming independent review.
Market Access Global comparator data signal “alarm bells” for UK Governmen... Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI.
Views & Analysis Beyond Brexit: how the UK can continue to attract foreign in... The UK will remain a world-class place for life sciences, regardless of Brexit – but overseas companies can benefit from experienced guides on how to set up and thrive here, say Mark Edwards an
Views & Analysis Brexit life sciences ‘beauty contest’ underway How the UK’s exit from the EU may influence pharma companies’ decisions to stay or go.
Views & Analysis Why does UK biotech struggle to generate leaders? Can the UK emulate America's culture of biotech entrepreneurship?